A Phase II Clinical Trial of Radium-223 Activity in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc) with Asymptomatic Progression While on Abiraterone Acetate or Enzalutamide Besides AR-V7 Mutational Status (EXCAAPE)
Annals of oncology（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined